Literature DB >> 7360238

Drug innovation--what's slowing it down?

F Steward, G Wibberley.   

Abstract

Mesh：

Year:  1980        PMID： 7360238     DOI： 10.1038/284118a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

Review 1.  Diagnosing the decline in pharmaceutical R&D efficiency.

Authors:  Jack W Scannell; Alex Blanckley; Helen Boldon; Brian Warrington
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

2.  Novel medicines marketed in the UK (1960-87).

Authors:  Y Lis; S R Walker
Journal:  Br J Clin Pharmacol       Date:  1989-09       Impact factor: 4.335

3.  Trends in the development of new medicines by UK-owned pharmaceutical companies (1964-1980).

Authors:  R A Prentis; S R Walker
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

4.  The regulatory control of non-steroidal anti-inflammatory agents.

Authors:  M N Dukes; I Lunde
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

5.  A survey of products licensed in the United Kingdom from 1971-1981.

Authors:  J P Griffin; G E Diggle
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

6.  The drug industry: the goose that lays the golden drugs.

Authors:  T Smith
Journal:  Br Med J       Date:  1980-11-08

7.  Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985).

Authors:  R A Prentis; Y Lis; S R Walker
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

Review 8.  Predictive validity in drug discovery: what it is, why it matters and how to improve it.

Authors:  Jack W Scannell; James Bosley; John A Hickman; Gerard R Dawson; Hubert Truebel; Guilherme S Ferreira; Duncan Richards; J Mark Treherne
Journal:  Nat Rev Drug Discov       Date:  2022-10-04       Impact factor: 112.288
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.